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ABSTRACT 
Aim of the Study 
The aim of the study is to determine the frequency of diagnoses of 
significant findings by upper GI endoscopy with ultra-sonogram proven gall 
stone disease with chronic dyspeptic symptoms. 
Objectives 
1. To study the prevalence of symptomatic dyspepsia in patients with 
cholelithiasis. 
2. To identify the co-incidence of gallstones with different upper GI 
pathology and to evaluate the role of upper GI endoscopy in patients 
with symptomatic gall stone disease. 
3. To study the age distribution on upper GI endoscopy in cholelithiasis 
patients with dyspepsia. 
4. To study sex distribution of various pathogenesis in upper GI 
endoscopy. 
5. To highlight the importance of endoscopic evaluation as a pre-op 
investigation in patients with dyspepsia and cholelithiasis. 
Hypothesis 
1. The incidence of clinically significant in upper GI endoscopy in 
cholelithisis Patients with dyspeptic complaints are less compared to 
the incidence of normal study 
2. The prevalence of positive endoscopic findings in symptomatic 
cholelithiasis disease patients are higher in women. 
3. The prevalence of positive findings are increasing with age. 
 
METHODOLOGY 
Using a OGD scope upper gastrointestinal tract was examined and 
results were observed and tabulated. 
CONCLUSION 
The prevalence of significant findings in upper gastrointestinal scopy 
of ultrasound proven symptomatic gall stone disease with chronic dyspepsia 
as symptoms is relatively higher than the prevalence of normal study. 
The significant findings in symptomatic patients prevalence is higher 
in females than males in all age groups. 
The prevalence of significant lesions was highest in the age group of 
>40 years. Increase in the age will be increase in the associated significant 
findings. 
The prevalence of gastritis as a single diagnoses is more prevalent in 
this part of the world and in our institution. 
Gall stone disease clinical symptoms is complex and may resemble 
other upper gastrointestinal disease. So using a upper GI scope should be 
made routine for all gall stone disease patients prior to elective surgical 
cholecystectomy. As it helps to identify other potential medically treatable 
diseases and hence cholecystectomy rates can be reduced. The postoperative 
persistence of symptoms will reduce due to single investigation. Thus upper 
gastrointestinal endoscopy has a very important and vital role in initial 
evaluation and investigation of patients with symptomatic gall stone disease. 
 
 TABLE OF CONTENTS 
S.NO TITLE PAGE 
NO 
1 INTRODUCTION 1 
2 REVIEW OF LITERATURE 3 
3 AIMS AND OBJECTIVES 8 
4 HYPOTHESIS 9 
5 MATERIALS AND METHODS 10 
6 RESULTS AND OBSERVATION 29 
7 DISCUSSION 70 
8 SUMMARY 74 
9 CONCLUSION 76 
10 LIMITATION AND SUGGESTIONS 77 
11 REFERENCES 78 
12 PROFORMA 83 
13 MASTER CHART 86 
 
 
 
 
1 
INTRODUCTION 
In India for past few years there is a marked increase in the 
incidence of gall stones and it is due to the advance techniques in 
imaging and lifestyle modification. 
Most of the studies show that asymptomatic gall stones are more 
than the symptomatic stones which are encountered during routine 
abdominal ultra-sonogram for various abdominal related problems. Many 
prospective studies shows that the asymptomatic gall stones does not 
cause complication during the life time. 
The symptomatic gall stones is of acute or chronic and the 
symptomatology of this disease is varied. Many patients with 
symptomatic cholelithiasis report persisting abdominal pain after 
cholecystectomy, suggesting alternative causes of these symptoms. This 
present study was conducted to determine the co-incidence of gallstones 
with symptomatic gallstones with different upper GI pathologies and to 
evaluate the role of upper GI endoscopy in patients with symptomatic 
gall stone disease. 
The symptoms and complication result from effects occurring 
within the gallbladder or from stones that escape the gallbladder to lodge 
in the CBD. 
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Chronic symptoms are usually dyspeptic classically referred to as 
flatulent dyspepsia. In these patients with chronic symptoms, it is 
important to stress that demonstration of gall stones does not exclude 
other disorders which may be responsible for the symptoms. 
Appropriate investigation protocol is important in patients with 
chronic symptoms and also for selecting patients for elective laparoscopic 
or open cholecystectomy. 
This study focuses on the yield of pre-op upper gastrointestinal 
scopy as an investigative modality to find other related disorders of upper 
gastrointestinal tract in cases with ultrasonogram proven gall bladder 
stones presenting with chronic dyspepsia symptoms. 
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REVIEW OF LITERATURE 
 The therapeutic role of upper gastrointestinal scopy has been 
studied in lot of studies and they gave us there valuable opinions 
regarding presence of overlapping other upper gastrointestinal symptoms. 
 In a study of Rassek et al, he suggested before elective open or 
laparascopy cholecystectomy upper gastrointestinal endoscopy is 
mandatory to perform. In his study, he conducted upper gastrointestinal 
scopy for 589 patients out of 960 patients before elective 
cholecystectomy. In a group of 589 patients 56% of patients had normal 
findings in upper GI scopy, in that 1103% i.e 113 patients had underwent 
change of plan of management due to upper gastroscopy findings and 
1.1% i.e 11 patients had treated conservatively by medical treatment and 
discharged. 
 There was a lot of studies in prospective method, which was done 
regarding emphasize the importance of OGD scopy usage before surgical 
treatment of gall stone disease. In one of his study, Diettrich et al, upper 
gastrointestinal endoscopy was done on 100 patients before elective open 
or laparascopy cholecystectomy for cholelithiasis. He found that 31% i.e 
31 patients had abnormal findings in OGD scopy which changed their 
management plan subsequently. He also recommended prior to surgical 
intervention for cholelithiasis a upper gastrointestinal scopy is very much 
needed to rule out other important upper gastrointestinal symptoms. 
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 In another study, Schwenk et al, he conducted OGD scopy for 
about 1143 patients prior elective open or laparascopy cholecystectomy, 
the incidence of abnormal upper GI findings was present in 30.2% i.e 345 
patients, in which about 68.3% was found to be inflammation in nature as 
a major cause. In 2.5% i.e 28 patients underwent surgical procedure with 
bile duct exploration with combination of additional surgical procedure. 
In 227 patients i.e 19.8% biliary procedure surgery was done followed by 
conservative medical treatment was done. Due to high incidence of other 
upper gastro intestinal diseases, he recommended that routine prior upper 
gastro intestinal endoscopy is mandatory before elective surgical 
management in gall stone diseases. 
 In a study, Thybusch et al, proved the importance of implication of 
upper gastrointestinal scopy findings before cholecystectomy. He 
choosed 338 patients who are planned to undergo surgical procedure 
cholecystectomy. In his observation nearly about 50% of patients had 
abnormal findings in OGD scopy. He had various findings in OGD scopy 
about 6.8% are peptic ulcer, 1.8% are gastric erosions, 25.7% are 
gastritis, 3.2% had polyps, hiatal hernia was present about 4.7%, 
esophagitis were in 3% and 0.6% gastric cancers was found. The plan of 
managements is changed in 8.3% of patients, although symptoms did not 
correlated with subjects findings, medical treatment was given to 26 
patients before undergoing any surgical procedure. In all these patients 
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two patients had gastric cancer and gastrectomy was done. He shown the 
importance of OGD scopy to evaluate before cholecystectomy. 
 In a retrospective study, Yavoriski et al, he found 9% of patients 
had abnormal OGD scopy findings in their study and he altered these 
patients management and concluded that before any cholelithiasis patient 
undergoing surgical procedure should undergo upper gastrointestinal 
endoscopy. 
 In another study, Sosada et al, conducted OGD scopy for about 
2800 patients who had abdominal pain with findings of cholelithiasis. In 
his study he used OGD scopy 1-4 days prior to elective surgical 
procedure and found about 42% i.e 1187 patients had abnormal 
pathological findings. The various pathological abnormalities were 
gastric ulcer in 6.4% i.e 179 patients, duodenal ulcer is 4.5% i.e 127 
patients, gastritis is 5.1% i.e 146 paients and gastric cancer is 0.1% i.e 3 
patients. The surgical procedure was not done to the patient with ulcer 
and these patients were treated with accordingly. About 16 patients was 
treated by medical treatment, for them cholecystectomy was not 
performed. 
 Beyermann et al, also done this study and concluded that, in 610 
patients he had only 11% abnormal findings in OGD scopy, but he too 
suggested routine upper gastrointestinal endoscopy testing should be 
done to all cholelithiasis patients. 
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 In a retrospective study of Rashid et al, who done routine OGD 
scopy prior to surgical procedure laparascopy cholecystectomy found 
coexisting abnormalities in about 33% of patients. For all those patients 
managements were changed. He also noticed that prior surgical procedure 
upper gastro endoscopy procedure reduces the recurrence or persistence 
of other symptoms. The patient who doesnot underwent upper GI 
endoscopy had higher recurrence and persistent symptoms in about 33% 
in compare to patients who underwent OGD scopy of about 3.3%. That 
why he suggested that upper GI scopy must be routine investigation 
before any surgical procedure of cholecystectomy especially with patients 
who overlap with other symptoms of upper gastro intestinal symptoms. 
His data concluded that before laparascopy cholecystectomy OGD scopy 
as a routine investigation will help to decrease the postoperative 
symptoms and may it will reduce recurrent surgical procedure rates. 
 The need and usefulness of upper GI scopy before any surgical 
procedure for cholelithiasis is gained importance and proved by many 
studies with evidence, but some where stated that there is no difference or 
any influence using endoscopy because postop outcome is similar to non 
using OGD scopy group. It was suggested by Ure et al, he told that prior 
upper GI endoscopy is neither useful nor cost effective for the cases who 
had typical cholelithiasis symptoms and not for coexisting symptoms. 
Even in his observation, he found abnormalities like peptic ulcer, gastric 
ulcer and esophagitis in ration of n=14,n=15 and n=11. He treated 30 
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patients by medical treatment and 2 by endoscopy polypectomy. The 
surgical procedure was cancelled for four patients who under upper GI 
scopy. 
 Similarly, Al-Asawi et al, compared two groups who underwent 
prior OGD scopy testing and group not underwent. In his study, out of 
400 patients 218 patients i.e 218 patients underwent OGD scopy. There 
were about 55% patients had abnormal findings. The abnormal findings 
noted was hiatus hernia of about 21%, acute duodenal ulcer 3.6%, 
esophagitis of about 3.6%, gastric ulcer in 0.4% and Barrett’s oesophagus 
in 0.4%. In six patients with chronic cholecystitis surgical procedure was 
deferred. In his study the residual post operative abdominal pain was not 
reduced in patients who underwent prior OGD scopy. Despite all the 
above findings he concluded that upper gastro intestinal endoscopy can 
identify other upper gastrointestinal disease with similar symptoms like 
gall stone disease. The upper GI scopy results can change the proposed 
surgical procedure in chronic cholecystitis. 
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AIM OF THE STUDY 
The aim of the study is to determine the frequency of diagnoses of 
significant findings by upper GI endoscopy with ultra-sonogram proven 
gall stone disease with chronic dyspeptic symptoms. 
OBJECTIVES 
1. To study the prevalence of symptomatic dyspepsia in patients with 
cholelithiasis. 
2. To identify the co-incidence of gallstones with different upper GI 
pathology and to evaluate the role of upper GI endoscopy in 
patients with symptomatic gall stone disease. 
3. To study the age distribution on upper GI endoscopy in 
cholelithiasis patients with dyspepsia. 
4. To study sex distribution of various pathogenesis in upper GI 
endoscopy. 
5. To highlight the importance of endoscopic evaluation as a pre-op 
investigation in patients with dyspepsia and cholelithiasis. 
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HYPOTHESIS 
1. The incidence of clinically significant in upper GI endoscopy in 
cholelithisis Patients with dyspeptic complaints are less compared 
to the incidence of normal study 
2. The prevalence of positive endoscopic findings in symptomatic 
cholelithiasis disease patients are higher in women. 
3. The prevalence of positive findings are increasing with age. 
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MATERIALS AND METHODS 
Site of study: 
The study was conducted in Department of Genaral Surgery at 
Government Stanley Medical College and Hospital. Chennai. 
Period of study: 
 June 2015 to May 2016 
Type of Study : RETROSPECTIVE STUDY 
Inclusion criteria: 
1. Patients age greater than 16 years 
2. Patients with ultra sonogram proven single or multiple gall bladder 
stone. 
3. Patients with any of the one or more following complaints. 
a. Pain in the epigastrium or right upper quadrant, 
b. Pain that begins post prandially, 
c. Pain that is constant, accompanied by nausea and vomiting 
d. Belching or bloating, indigestion. 
4. Patients who are willing to participate in the study with written 
consent. 
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Exclusion criteria: 
1. Patients age less than 16 years 
2. Patients with acute abdomen or colicky pain 
3. Patients who are unstable 
4. Patients who are not willing to participate or not willing to sign the 
consent. 
Ethical committee approval 
 This study submitted for approval of the ethical committee at 
Dean’s office at Government Stanley Medical College Hospital and the 
approval was obtained. 
Sample size: 
 112 patients 
Selection of study subjects: 
 Patients presenting to the general surgery out-patient department 
and the referred patients from other departments with symptomatic 
cholelithiasis fulfilling the inclusion criteria are included in the study. 
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Tools used: 
Flexible endoscope 
Endoscope may have rigid or flexible tube inserted into body. It 
had the ability to looking inside the body, it facilitates direct viewing the 
interior of an organ.  
An endoscope is a flexible tube equipped with lenses and a light 
source, illuminations done by optic fibers and the video endoscopy by 
attaching in microchip camera at the insertion tube, set up image is 
viewed on a video monitor. It has a suction channel for passage of 
diagnostic tools and devises and a biopsy channel for suction of sample 
tissue. 
Procedure of study: 
The patients fulfilling the inclusion criteria either from general 
surgery out-patient department or referred from other departments are 
selected. 
Complaints and history of the patient taken with a proforma, 
general and physical examination done and endoscopy is performed in 
the general surgery endoscopy room in new surgical block. An informed 
consent was obtained from all patients prior to the procedure.   
 
 
 
13 
Patient preparation 
Prior to scheduling the procedure the selected patients who are 
participating in this study should be nil per oral for at least 6 hours. 
Intravenous wide bore line placed prior to the procedure. No intravenous 
sedation was given. The oral dentures and eye glasses were removed 
before the procedure. No antibiotics given prophylactically. 1% 
lignocaine jelly was applied to the endoscope to prevent the gag reflex 
when in contact with pharyngeal wall. Patient placed in lateral decubitus 
position with slightly elevated head on pillow. 
Diagnostic technique 
The routine diagnostic endoscopy is the 120 cm forward viewing 
endoscope is preferred. 
A trained assistant at the patient head end. The assistant protects 
the airway with suction throughout the procedure. And holds the 
endoscope when inserted and maintain the position of the mouth piece. 
After complete arrangements and making sure the equipments are 
in working condition and patient in comfort position the endoscope is 
lubricated with jelly and slowly inserted through the mouthpiece by 
advancing over the tongue, uvula, epiglottis, and to the cricoarytenoid 
posteriorly. Over the upper esophageal sphincter the tip of the endoscope 
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is placed which allows the endoscope to enter into cervical part of 
esophagus as the patient swallows. 
Under direct vision the endoscope is advanced up to the proximal 
part of the duodenum. The inspection and the sampling of the mucosa is 
done well during this period of time by withdrawing and insertion as the 
viscera is well distended with the air. 
The esophagus refers to the anatomical region which ranges from 
the UES to GEJ, which is subdivided into three portions: upper, middle, 
and lower. The UES is 15 cm away from the incisor, while the GEJ lies 
45 cm away from it. The important landmarks are the cricopharyngeal, 
the lower esophageal sphincter, pylorus and the superior duodenal angel 
are noted. 
The left hand usually grabs the control section and the right hand 
pinches the distal end of the scope. The left palm and hand grips the 
scope with fourth and fifth fingers. With the first finger on the large angle 
knob, the second finger on the suction button and the third finger on the 
air/water supply button, and can be freely manipulate the scope with the 
tip of each finger. 
The endoscope is rapidly advanced to the gastro esophageal 
junction where the squamous epithelium turns into columnar gastric 
epithelium. Within 2 cm of the diaphragmatic pinch cock which marks 
the diaphragmatic hiatus this point appreciated by instructing the patient 
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to sniff during visualization. When the endoscope passes through the GEJ 
into stomach it has to be rotated anticlockwise, the distal tip of the shaft 
need to be deflected in the upward direction. As the scope properly 
inserted into stomach. A gastric fold, the greater curvature of the body of 
stomach are observed, as the scope rotated into right in the same direction 
of the fold, the scope can enter into the antrum of the stomach where 
there is no fold. Advancing the scope further into distal antrum to observe 
pyloric ring which lead to duodenal bulb. All the areas should be 
carefully seen as the scope is gradually withdrawn. 
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NORMAL OESOPHAGUS ENDOSCOPY IMAGE 
 
NORMAL ESOPHAGUS AND GE JUNCTION. 
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NORMAL GASTRIC MUCOSA IMAGE IN ENDOSCOPY 
 
NORMAL PYLORUS IMAGE IN ENDOSCOPY 
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NORMAL DUODENUM MUCOSAL IMAGE IN ENDOSCOPY 
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Complication 
An endoscopy is usually a safe procedure and the risk of serious 
complications is very low and may vary mild to life threatening. Based 
on the degree of patients disturbance can be used to subdivide 
complication. 
 Mild – hospital stay for 1-3 days 
 Moderate – hospital stay for 4-9 days 
 Severe – hospital stay more than 10 days or surgery 
 Fatal – death due to procedure. 
Specific event 
Hypoxia 
 Should be monitor carefully during the procedure using pulse 
oximetry. 
Pulmonary aspiration 
 During the procedure or after bleeding may occur from the existing 
lesion or because of endoscopic manipulation e.g. Biopsy polypectomy or 
due to the Mallory Weiss tear. The patients are at greater risk who are 
with coagulopathy and those taking medication anticoagulants.  
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Perforation 
 Most worried complication of upper gastrointestinal endoscopy. 
The commonest site is at the neck and more commonly seen in elderly 
patients and this complication is reduced by careful insertion of the 
endoscopy. 
Cardiac dysrhythmias 
 An irregular rhythm may occur during the procedure and it is 
extremely rare. But it almost resolve without treatment sometimes may 
require expert opinion. 
Infection 
 Transient bacteremia may occur during most endoscopic 
procedures. The endoscopes are the mode of transmission of infection. 
Antibiotic prophylaxsis is recommended for all high risk patients. This 
risk is eliminated proper attention by cleaning and disinfection of the 
procedure instruments. 
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Recognition of lesion 
Esophagitis 
 The earliest finding is mucosal edema and congestion with 
alteration of vascular pattern. There will be mucosal breaks confined to a 
mucosal fold and lesion that’s extend throughout the esophageal 
circumference. At advance stages the mucosa bleeds of touch and 
becomes more friable, patches of exudate and ulceration is seen. In 
barrett’s esophagitis the relationship of the squamocolumnar mucosal 
junction to the proximal margin of the gastric folds and the distal extent 
of the linear esophageal vessel is the principle landmark for the diagnosis. 
Monilial esophagitis is an opportunistic infection of the esophagus and it 
is characterized by classic diffuse raised plaques that characteristically 
can be removed from the mucosa by the endoscope. 
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ENDOSCOPY IMAGE SHOWING REFLUX ESOPHAGITIS, 
Esophageal carcinoma: 
 Asymmetrical stenosis, with abnormal mucsa and sometimes 
irregular ulcer with raised edges. Fundal carcinoma may infiltrate the 
lower end of esophagus. Accurate diagnosis can be made when the 
endoscope is passed through the stricture to view the cardia of the 
stomach. 
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Stomach: 
 Gastric ulcer and erosions are the most common lesions. 
Gastric erosion:  
 Erosions are the lesions less than 5 mm and without scar. In antrum 
acute erosions are seen sometimes it are obscured by clots. Edematous 
erosions appear small, smooth, umblicated raised areas and are often in 
chains along the folds of gastric body. It is said chronic if multiple lesion 
are seen. 
Gastric ulcers: 
 Most commonly seen over the lesser curvature or above the 
angulus and usually in single. They are typically symmetrical with 
smooth margin and clean base. Patients taking analgesics for long period 
of time will have multiple punched out lesions. 
Gastric malignancy: 
 An ulcer with a mucosal abnormality surrounding it, raised 
irregular margins and a lumpy hemorrhagic base. Usually the mucosal 
folds around the ulcer will not reach upto margin of malignancy 
suspected. 
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IMAGE SHOWING ACUTE GASTRITIS 
 
IMGAGE SHOWING GASTRITIS 
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ENDOSCOPY IMAGE SHOWING GASTRIC ULCER. 
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Duodenum: 
Duodenitis: 
 Areas of mucosal congestion with spotty white exudates (salt and 
pepper ulceration) merge into even less definite macroscopic appearances 
labelled as duodenitis. 
Duodenal ulcer: 
 It either current or previous often cause persistent deformity of 
pyloric ring. They are frequently multiple and most commonly found in 
anterior and posterior walls of the bulb. If the ulcers are active it will be 
surrounded by oedema and acute congestion. A characteristic shelf like 
deformity of the duodenum will be formed due to scarring which partially 
divides the bulb and may produce a pseudo diverticulum; a small linear 
ulcer or scar is seen running on the apex of the fold. 
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ENDOSCOPY IMAGE SHOWING DUODENITIS 
 
 
ENDOSCOPY IMAGE SHOWING DUODENAL ULCER. 
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Hiatus hernia: 
 The diagnoses of the hiatus hernia is done by asking the patient to 
take a deep breath and is recorded as the distance from the incisors. The 
relationship of the Z-line to the diaphragmatic pinch cock varies during 
an endoscopy in different patients. In normal individuals, the Z line is 
often seen at least 1 cm above the diaphragm. Hiatus hernia is diagnosed 
is the Z line remains more than 2 cm above the hiatus.  
 
ENDOSCOPY IMAGE SHOWING HIATUS HERNIA 
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RESULTS AND OBSERVATIONS 
Socio demographic characteristics of subjects 
 
1. AGE DISTRIBUTION OF TOTAL SUBJECTS 
 
 
Subjects <40 years of age predominated the study group 
comprising 54.5% of the total. 
 
  
Frequency Percent
Valid 
Percent
Cumulativ
e Percent
Upto 20 
yrs
2 1.8 1.8 1.8
21 - 40 yrs 59 52.7 52.7 54.5
41 - 60 yrs 38 33.9 33.9 88.4
Above 60 
yrs
13 11.6 11.6 100.0
Total 112 100.0 100.0
Valid
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AGE DISTRIBUTION OF TOTAL SUBJECTS 
 
 
Subjects below the age of 40 years comprised the majority of the 
study population. 
 
 
 
0
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20
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2. GENDER DISTRIBUTION OF TOTAL SUBJECTS 
 
 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid 
Female 82 73.2 73.2 73.2 
Male 30 26.8 26.8 100.0 
Total 112 100.0 100.0 
 
 
Females comprised the majority (73%) of the study population. 
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GENDER DISTRIBUTION OF SUBJECTS 
 
 
 Females comprised the majority (73%) of the study population. 
 
 
 
 
Female 
73% 
Male 
27% 
GENDER DISTRIBUTION 
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3. DISTRIBUTION OF SUBJECTS WITH NORMAL STUDY 
ENDOSCOPIC 
FINDINGS 
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 
 
SIGNIFICANT 
LESIONS 
82 73.2 73.2 73.2 
NORMAL 30 26.8 26.8 100.0 
Total 112 100.0 100.0 
 
 
Significant lesions were found in the majority i.e. 73.2% of the 
total subjects. 
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AGE RANGE OF NORMAL STUDY SUBJECTS 
 
Among age range of normal study above 40 years subjects have 
84.3% chance of significant lesions. 
 
 
 
 
NO YES
Count 0 2 2
% within 
NORMAL
0.0% 6.7% 1.8%
Count 39 20 59
% within 
NORMAL
47.6% 66.7% 52.7%
Count 30 8 38
% within 
NORMAL
36.6% 26.7% 33.9%
Count 13 0 13
% within 
NORMAL
15.9% 0.0% 11.6%
Count 82 30 112
% within 
NORMAL
100.0% 100.0% 100.0%
NORMAL
Total
Agerange Upto 20 
yrs
21 - 40 yrs
41 - 60 yrs
Above 60 
yrs
Total
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DISTRIBUTION  OF AGE RANGE IN NORMAL  
STUDY SUBJECTS 
 
Young individuals has least chance of significant lesions. As age 
increases chance of getting significant lesions increases. 
Chi-Square Tests 
 
 
Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 12.382
a
 3 .006 
Likelihood Ratio 15.494 3 .001 
N of Valid Cases 112 
   
p-value is significant with increase in age is shown by above test. 
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GENDER DISTRIBUTION OF NORMAL  
STUDY SUBJECTS 
 
 
Among 82 female patients normal study was in 24 patients so 
29.2% of patients have normal study. 
Among 30 male patients normal study was in 6 patients so 20% 
have normal study. 
 
 
 
 
NO YES
Count 58 24 82
% within 
NORMAL
70.7% 80.0% 73.2%
Count 24 6 30
% within 
NORMAL
29.3% 20.0% 26.8%
Count 82 30 112
% within 
NORMAL
100.0% 100.0% 100.0%
SEX F
M
Total
NORMAL
Total
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GENDER DISTRIBUTION OF NORMAL  
STUDY SUBJECTS 
 
 
Here p-value is not significant. 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
NO YES
 NORMAL 
Female Male
Value df
Asymp. 
Sig. (2-
sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson 
Chi-
Square
.962
a 1 .327
Continuity 
Correction
b
.548 1 .459
Likelihood 
Ratio
1.002 1 .317
Fisher's 
Exact Test
.470 .232
N of Valid 
Cases
112
a. 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 8.04.b. Computed only for a 2x2 table
Chi-Square Tests
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4. DISTRIBUTION OF VARIOUS ENDOSCOPY  
FINDINGS 
ENDOSCOPY FINDING YES NO 
NORMAL STUDY 26.8% 73.2% 
GASTRITIS 48.2% 51.8% 
GASTRIC ULCER 1.8% 98.2% 
DUODENITIS 25.9% 74.1% 
DUODENAL ULCER 1.8% 98.2% 
REFLUX ESOPHAGITIS 11.6% 88.4% 
HIATUS HERNIA 9.8% 90.2% 
 
Among the significant lesions found on endoscopy, the commonest 
finding was gastritis (48.2%) followed by duodenitis (25.9%). 
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DISTRIBUTION OF VARIOUS SIGNIFICANT FINDINGS IN 
ENDOSCOPY 
SIGNIFICANT LESIONS IN PERCENTAGE 
 
Gastritis and Duodenitis is the commonest findings in both male 
and female patients. 
 
 
 
 
51.8 
98.2 
74.1 
98.2 
90.2 88.4 
73.2 
48.2 
1.8 
25.9 
1.8 
9.8 11.6 
26.8 
0%
10%
20%
30%
40%
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60%
70%
80%
90%
100%
NO YES
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5. DISTRIBUTION OF SUBJECTS WITH GASTRITIS 
 
 
Gastritis is the most commonest findings found in all subjects with 
highest percentage of 48.2%. 
 
 
 
 
 
 
 
 
 
Frequency Percent
Valid 
Percent
Cumulativ
e Percent
NO 58 51.8 51.8 51.8
YES 54 48.2 48.2 100.0
Total 112 100.0 100.0
GASTRITIS
Valid
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AGE DISTRIBUTION OF SUBJECTS WITH GASTRITIS 
 
Among individuals age range between with 21-40 years are more 
affected. 
 
 
 
 
NO YES
Count 2 0 2
% within 
GASTRITI
S
3.4% 0.0% 1.8%
Count 37 22 59
% within 
GASTRITI
S
63.8% 40.7% 52.7%
Count 17 21 38
% within 
GASTRITI
S
29.3% 38.9% 33.9%
Count 2 11 13
% within 
GASTRITI
S
3.4% 20.4% 11.6%
Count 58 54 112
% within 
GASTRITI
S
100.0% 100.0% 100.0%
GASTRITIS
Total
Agerange Upto 20 
yrs
21 - 40 yrs
41 - 60 yrs
Above 60 
yrs
Total
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AGE DISTRIBUTION OF SUBJECTS WITH GASTRITIS 
 
 
 
 
 
p-value for gastritis is significant. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
NO YES
 GASTRITIS 
Upto 20 yrs 21 - 40 yrs 41 - 60 yrs Above 60 yrs
Value df
Asymp. 
Sig. (2-
sided)
Pearson 
Chi-
Square
12.338
a 3 .006
Likelihood 
Ratio
13.767 3 .003
N of Valid 
Cases
112
Chi-Square Tests
a. 2 cells (25.0%) have expected count less 
than 5. The minimum expected count is .96.
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SEX DISTRIBUTION OF SUBJECTS WITH GASTRITIS 
 
 
Sex distribution of gastritis, females are higher than males. 
 
 
 
 
 
 
NO YES
Count 47 35 82
% within 
GASTRITI
S
81.0% 64.8% 73.2%
Count 11 19 30
% within 
GASTRITI
S
19.0% 35.2% 26.8%
Count 58 54 112
% within 
GASTRITI
S
100.0% 100.0% 100.0%
GASTRITIS
Total
SEX F
M
Total
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SEX DISTRIBUTION OF SUBJECTS WITH GASTRITIS 
 
 
 
p- value is not significant. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
NO YES
 GASTRITIS 
Female Male
Value df
Asymp. 
Sig. (2-
sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson 
Chi-
Square
3.751
a 1 .053
Continuity 
Correction
b
2.970 1 .085
Likelihood 
Ratio
3.779 1 .052
Fisher's 
Exact Test
.058 .042
N of Valid 
Cases
112
a. 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 14.46.b. Computed only for a 2x2 table
Chi-Square Tests
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6. DISTRIBUTION OF SUBJECTS WITH  
GASTRIC ULCER 
 
  
Among the individuals gastric ulcer was diagnosed in only 1.8% of 
subjects. 
 
 
 
 
Frequency Percent
Valid 
Percent
Cumulativ
e Percent
NO 110 98.2 98.2 98.2
YES 2 1.8 1.8 100.0
Total 112 100.0 100.0
GASTRIC ULCER
Valid
 
 
46 
 
 
AGE DISTRIBUTION OF SUBJECTS WITH  
GASTRIC ULCER 
 
 
 
 
NO YES
Count 2 0 2
% within 
GASTRIC 
ULCER
1.8% 0.0% 1.8%
Count 59 0 59
% within 
GASTRIC 
ULCER
53.6% 0.0% 52.7%
Count 36 2 38
% within 
GASTRIC 
ULCER
32.7% 100.0% 33.9%
Count 13 0 13
% within 
GASTRIC 
ULCER
11.8% 0.0% 11.6%
Count 110 2 112
% within 
GASTRIC 
ULCER
100.0% 100.0% 100.0%
GASTRIC ULCER
Total
Agerange Upto 20 
yrs
21 - 40 yrs
41 - 60 yrs
Above 60 
yrs
Total
 
 
47 
 
AGE DISTRIBUTION OF SUBJECTS WITH  
GASTRIC ULCER 
 
 
 
p-value is not significant in gastric ulcer. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
NO YES
GASTRIC ULCER 
Upto 20 yrs 21 - 40 yrs 41 - 60 yrs Above 60 yrs
Value df
Asymp. 
Sig. (2-
sided)
Pearson 
Chi-
Square
3.966
a 3 .265
Likelihood 
Ratio
4.395 3 .222
N of Valid 
Cases
112
Chi-Square Tests
a. 5 cells (62.5%) have expected count less 
than 5. The minimum expect d count is .04.
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SEX DISTRIBUTION OF SUBJECTS WITH  
GASTRIC ULCER 
 
 
Among gastric ulcer females are more affected than males. 
 
 
 
NO YES
Count 80 2 82
% within 
GASTRIC 
ULCER
72.7% 100.0% 73.2%
Count 30 0 30
% within 
GASTRIC 
ULCER
27.3% 0.0% 26.8%
Count 110 2 112
% within 
GASTRIC 
ULCER
100.0% 100.0% 100.0%
GASTRIC ULCER
Total
SEX F
M
Total
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SEX DISTRIBUTION OF SUBJECTS WITH  
GASTRIC ULCER 
 
 
 
p- value is not significant for gastric ulcer. 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
NO YES
GASTRIC ULCER 
Female Male
Value df
Asymp. 
Sig. (2-
sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson 
Chi-
Square
.745
a 1 .388
Continuity 
Correction
b
.003 1 .954
Likelihood 
Ratio
1.260 1 .262
Fisher's 
Exact Test
1.000 .534
N of Valid 
Cases
112
a. 2 cells (50.0%) have expected count less than 5. The minimum 
expected count is .54.b. Computed only for a 2x2 table
Chi-Square Tests
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7. DISTRIBUTION OF SUBJECTS WITH DUODENITIS 
 
 
Duodenitis is the second most common findings in OGD scope 
with 25.9% 
 
 
 
 
 
Frequency Percent
Valid 
Percent
Cumulativ
e Percent
NO 83 74.1 74.1 74.1
YES 29 25.9 25.9 100.0
Total 112 100.0 100.0
DUODENITIS
Valid
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AGE DISTRIBUTION OF SUBJECTS  
WITH DUODENITIS 
 
 
 
Duodenitis among subjects second common findings in upper 
gastrointestinal endoscopy. 
 
 
 
NO YES
Count 2 0 2
% within 
DUODENI
TIS
2.4% 0.0% 1.8%
Count 46 13 59
% within 
DUODENI
TIS
55.4% 44.8% 52.7%
Count 26 12 38
% within 
DUODENI
TIS
31.3% 41.4% 33.9%
Count 9 4 13
% within 
DUODENI
TIS
10.8% 13.8% 11.6%
Count 83 29 112
% within 
DUODENI
TIS
100.0% 100.0% 100.0%
DUODENITIS
Total
Agerange Upto 20 
yrs
21 - 40 yrs
41 - 60 yrs
Above 60 
yrs
Total
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AGE DISTRIBUTION OF SUBJECTS WITH DUODENITIS 
 
 
 
 
p-value is not significant.  
Duodenitis is more likely increase with age in the subjects. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
NO YES
DUODENITIS 
Upto 20 yrs 21 - 40 yrs 41 - 60 yrs Above 60 yrs
Value df
Asymp. 
Sig. (2-
sided)
Pearson 
Chi-
Square
1.958
a 3 .581
Likelihood 
Ratio
2.441 3 .486
N of Valid 
Cases
112
Chi-Square Tests
a. 3 cells (37.5%) have expected count less 
than 5. The minimum expected count is .52.
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SEX DISTRIBUTION OF SUBJECTS  
WITH DUODENITIS 
 
 
Duodenitis is second more common after gastritis in the endoscopy 
findings and it is more prevalent in female subjects than in males. 
 
 
NO YES
Count 59 23 82
% within 
DUODENI
TIS
71.1% 79.3% 73.2%
Count 24 6 30
% within 
DUODENI
TIS
28.9% 20.7% 26.8%
Count 83 29 112
% within 
DUODENI
TIS
100.0% 100.0% 100.0%
DUODENITIS
Total
SEX F
M
Total
 
 
54 
SEX DISTRIBUTION OF SUBJECTS  
WITH DUODENITIS 
 
 
 
 
 
p-value is not significant for duodenitis. 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
NO YES
DUODENITIS 
Female Male
Value df
Asymp. 
Sig. (2-
sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson 
Chi-
Square
.742
a 1 .389
Continuity 
Correction
b
.381 1 .537
Likelihood 
Ratio
.769 1 .380
Fisher's 
Exact Test
.471 .273
N of Valid 
Cases
112
a. 0 cells (0.0%) have expected count less than 5. The minimum 
expected count is 7.77.b. Computed only for a 2x2 table
Chi-Square Tests
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8. DISTRIBUTION OF SUBJECTS WITH  
DUODENAL ULCER 
 
 
Only 1.8% of patients had duodenal ulcer significant lesions 
 
 
 
 
 
 
Frequency Percent
Valid 
Percent
Cumulativ
e Percent
NO 110 98.2 98.2 98.2
YES 2 1.8 1.8 100.0
Total 112 100.0 100.0
DUODENAL ULCER
Valid
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AGE DISTRIBUTION OF SUBJECTS WITH  
DUODENAL ULCER 
 
Among individuals age above 60 and 21-40years had significant 
lesions. 
 
NO YES
Count 2 0 2
% within 
DUODEN
AL ULCER
1.8% 0.0% 1.8%
Count 58 1 59
% within 
DUODEN
AL ULCER
52.7% 50.0% 52.7%
Count 38 0 38
% within 
DUODEN
AL ULCER
34.5% 0.0% 33.9%
Count 12 1 13
% within 
DUODEN
AL ULCER
10.9% 50.0% 11.6%
Count 110 2 112
% within 
DUODEN
AL ULCER
100.0% 100.0% 100.0%
DUODENAL ULCER
Total
Agerange Upto 20 
yrs
21 - 40 yrs
41 - 60 yrs
Above 60 
yrs
Total
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AGE DISTRIBUTION OF SUBJECTS WITH  
DUODENAL ULCER 
 
 
 
 
p-value is not significant. 
 
0%
20%
40%
60%
80%
100%
NO YES
DUODENAL ULCER 
Upto 20 yrs 21 - 40 yrs 41 - 60 yrs Above 60 yrs
Value df
Asymp. 
Sig. (2-
sided)
Pearson 
Chi-
Square
3.316
a 3 .345
Likelihood 
Ratio
2.877 3 .411
N of Valid 
Cases
112
Chi-Square Tests
a. 5 cells (62.5%) have expected count less 
than 5. The minimum expected count is .04.
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SEX DISTRIBUTION OF SUBJECTS WITH  
DUODENAL ULCER 
 
 
   Among individuals females are more affected than males. 
 
 
NO YES
Count 80 2 82
% within 
DUODEN
AL ULCER
72.7% 100.0% 73.2%
Count 30 0 30
% within 
DUODEN
AL ULCER
27.3% 0.0% 26.8%
Count 110 2 112
% within 
DUODEN
AL ULCER
100.0% 100.0% 100.0%
DUODENAL ULCER
Total
SEX F
M
Total
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SEX DISTRIBUTION OF SUBJECTS WITH  
DUODENAL ULCER 
 
 
 
 
p-value is not significant. 
0%
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40%
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60%
70%
80%
90%
100%
NO YES
DUODENAL ULCER 
Female Male
Value df
Asymp. 
Sig. (2-
sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson 
Chi-
Square
.745
a 1 .388
Continuity 
Correction
b
.003 1 .954
Likelihood 
Ratio
1.260 1 .262
Fisher's 
Exact Test
1.000 .534
N of Valid 
Cases
112
a. 2 cells (50.0%) have expected count less than 5. The minimum 
expected count is .54.b. Computed only for a 2x2 table
Chi-Square Tests
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9. DISTRIBUTION OF SUBJECTS WITH  
HIATUS HERNIA 
 
 
Among individuals 9.8% of subjects had hiatus hernia. 
 
 
 
 
 
 
Frequency Percent
Valid 
Percent
Cumulativ
e Percent
NO 101 90.2 90.2 90.2
YES 11 9.8 9.8 100.0
Total 112 100.0 100.0
HIATUS HERNIA
Valid
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AGE DITRIBUTION OF SUBJECTS WITH  
HIATUS HERNIA 
 
 
Among individuals age range between 21-40 years had hiatus 
hernia incidence more. 
 
 
 
 
NO YES
Count 2 0 2
% within 
HIATUS 
HERNIA
2.0% 0.0% 1.8%
Count 51 8 59
% within 
HIATUS 
HERNIA
50.5% 72.7% 52.7%
Count 36 2 38
% within 
HIATUS 
HERNIA
35.6% 18.2% 33.9%
Count 12 1 13
% within 
HIATUS 
HERNIA
11.9% 9.1% 11.6%
Count 101 11 112
% within 
HIATUS 
HERNIA
100.0% 100.0% 100.0%
HIATUS HERNIA
Total
Agerange Upto 20 
yrs
21 - 40 yrs
41 - 60 yrs
Above 60 
yrs
Total
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AGE DISTRIBUTION OF SUBJECTS WITH  
HIATUS HERNIA 
 
More incidence of hiatus hernia is present in age between 21-40 years. 
 
p-value is not significant. 
0%
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20%
30%
40%
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60%
70%
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90%
100%
NO YES
HIATUS HERNIA 
Upto 20 yrs 21 - 40 yrs 41 - 60 yrs Above 60 yrs
Value df
Asymp. 
Sig. (2-
sided)
Pearson 
Chi-
Square
2.107
a 3 .551
Likelihood 
Ratio
2.382 3 .497
N of Valid 
Cases
112
Chi-Square Tests
a. 4 cells (50.0%) have expected count less 
than 5. The minimum expected count is .20.
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SEX DISTRIBUTION OF SUBJECTS WITH  
HIATUS HERNIA 
 
 
Females are more affected in the examined group. 
 
 
 
 
 
 
 
 
NO YES
Count 74 8 82
% within 
HIATUS 
HERNIA
73.3% 72.7% 73.2%
Count 27 3 30
% within 
HIATUS 
HERNIA
26.7% 27.3% 26.8%
Count 101 11 112
% within 
HIATUS 
HERNIA
100.0% 100.0% 100.0%
HIATUS HERNIA
Total
SEX F
M
Total
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SEX DISTRIBUTION OF SUBJECTS WITH 
HIATUS HERNIA 
 
 
Females are more affected in hiatus hernia than males. 
 
 
p-value is not significant. 
 
0%
20%
40%
60%
80%
100%
NO YES
HIATUS HERNIA 
Female Male
Value df
Asymp. 
Sig. (2-
sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson 
Chi-
Square
.001
a 1 .969
Continuity 
Correction
b
0.000 1 1.000
Likelihood 
Ratio
.001 1 .969
Fisher's 
Exact Test
1.000 .608
N of Valid 
Cases
112
b. Computed only for a 2x2 table
Chi-Square Tests
a. 1 cells (25.0%) have expected count less than 5. The minimum 
expected count is 2.95.
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10. DISTRIBUTION OF SUBJECTS WITH  
REFLUX ESOPHAGITIS 
 
 
Among individuals reflux oesophagitis was 11.6%. 
 
 
 
 
 
 
 
Frequency Percent
Valid 
Percent
Cumulativ
e Percent
NO 99 88.4 88.4 88.4
YES 13 11.6 11.6 100.0
Total 112 100.0 100.0
REFLUX ESOPHAGITIS
Valid
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AGE DISTRIBUTION OF SUBJECTS WITH  
REFLUX ESOPHAGITIS 
 
Among individuals age range between 21-40 years are more 
affected. 
 
 
NO YES
Count 2 0 2
% within 
REFLUX 
ESOPHAG
ITIS
2.0% 0.0% 1.8%
Count 52 7 59
% within 
REFLUX 
ESOPHAG
ITIS
52.5% 53.8% 52.7%
Count 33 5 38
% within 
REFLUX 
ESOPHAG
ITIS
33.3% 38.5% 33.9%
Count 12 1 13
% within 
REFLUX 
ESOPHAG
ITIS
12.1% 7.7% 11.6%
Count 99 13 112
% within 
REFLUX 
ESOPHAG
ITIS
100.0% 100.0% 100.0%
REFLUX 
ESOPHAGITIS
Total
Agerange Upto 20 
yrs
21 - 40 yrs
41 - 60 yrs
Above 60 
yrs
Total
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AGE DISTRIBUTION OF SUBJECTS WITH REFLUX 
ESOPHAGITIS 
 
Among individuals age range 21-40 years is more affected. 
 
 
p-value is not significant. 
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NO YES
REFLUX ESOPHAGITIS 
Upto 20 yrs 21 - 40 yrs 41 - 60 yrs Above 60 yrs
Value df
Asymp. 
Sig. (2-
sided)
Pearson 
Chi-
Square
.550
a 3 .908
Likelihood 
Ratio
.800 3 .849
N of Valid 
Cases
112
Chi-Square Tests
a. 4 cells (50.0%) have expected count less 
than 5. The minimum expected count is .23.
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SEX DISTRIBUTION OF SUBJECTS WITH  
REFLUX ESOPHAGITIS 
 
Among individuals females are more affected than males. 
 
 
 
NO YES
Count 73 9 82
% within 
REFLUX 
ESOPHAG
ITIS
73.7% 69.2% 73.2%
Count 26 4 30
% within 
REFLUX 
ESOPHAG
ITIS
26.3% 30.8% 26.8%
Count 99 13 112
% within 
REFLUX 
ESOPHAG
ITIS
100.0% 100.0% 100.0%
REFLUX 
ESOPHAGITIS
Total
SEX F
M
Total
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SEX DISTRIBUTION OF SUBJECTS WITH  
REFLUX ESOPHAGITIS 
 
 
Among individuals females are more affected with males. 
 
 
p-value is not significant. 
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NO YES
REFLUX ESOPHAGITIS 
Female Male
Value df
Asymp. 
Sig. (2-
sided)
Exact Sig. 
(2-sided)
Exact Sig. 
(1-sided)
Pearson 
Chi-
Square
.119
a 1 .730
Continuity 
Correction
b
.000 1 .991
Likelihood 
Ratio
.116 1 .733
Fisher's 
Exact Test
.744 .479
N of Valid 
Cases
112
a. 1 cells (25.0%) have expected count less than 5. The minimum 
expected count is 3.48.b. Computed only for a 2x2 table
Chi-Square Tests
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DISCUSSION 
The endoscopy findings recorded in a proforma for all dyspeptic 
patients with ultrasound proven gall stone by age and sex. The prevalence 
of all the significant lesions in upper GI scopy was derived and their age 
and sex distribution charts were made out. All datas tables and 
interpretations are presented as the observations and the results tabulated. 
 Now let us discuss the results of the present study with literature 
back ground and compare with hypothesis. 
Hypothesis 1: 
The incidence of clinically significant findings in upper GI 
endoscopy in cholelithisis patients with dyspeptic complaints are less 
compared to the incidence of normal study. 
Among the 112 patients with symptomatic gall stones, abnormal 
study of upper gastrointestinal tract was found in 82 patients forming 
73.2% of total patients.       
The results doesn’t go in accordance with Ure et al, Yavorski et al, 
schwenk et al which concluded saying that only <30% of patients with 
symptomatic gall stones disease patients had significant focal or 
structural lesion in upper gastrointestinal tract at endoscopy. 
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Among the 112 patients 82 patients had significant findings 
forming 73.2% of symptomatic gall stone disease population. This result 
is not accordance with above study which states that only < 30% had 
significant findings in endoscopy. The difference can be explained by the 
fact that 1. The sample size of the present study is relatively small 
compared to other studies. 2.Stanley medical college hospital being a 
teritiary centre specializing in surgical field the referrals tend to have 
more significant lesions as the patients are generally treated already 
somewhere conservatively by general practitioner in the community. 
But the present study goes in accordance with Thybusch et al, 
Dhaliwal et al, Rassek et al which concluded that significant findings 
were identified in >50% of symptomatic gall stone patients. 
Hypothesis 2: 
(The prevalence of positive findings is higher in women than men) 
Of the 112 patients,   82 subjects were females forming 73.2% of 
the total subjects. 
In that 82 females, 58 patients had significant findings in 
endoscopy which is 70.7%. 
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Hypothesis 3: 
(The prevalence of positive findings in symptomatic gall stones 
cases increases with age) 
Among 112 patients, 51 patients are aged above 40 years of age 
and in that 43 patients had significant lesions in endoscopy which is 
84.3% of total subjects. 
Among the 51 patients, the prevalence of positive findings were 
84.3%, 100% in the age frequencies fo <40-60yrs and >60 years of age. 
Thus the prevalence of positive findings was found to be higher while the 
age increases. 
Among the various endoscopically significant findings gastritis 
was present almost 48.2% of cases which comprises the maximum 
amount. Then comes duodenitis which is about 25.9% second to gastritis. 
Hiatus hernia comprised of about 9.8% of patients while the 
incidence was around 6% in Dhaliwal et al study. 
Reflux esophagitis comprised of about 11.6% which resembles 
Thybach et al study. 
Gastric ulcer and Duodenal ulcer comprised of 1.8% each which is 
least among the significant findings in symptomatic gall stone disease. 
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In the present study, p-value for gastritis and age above 60 yrs is 
significant  which resembles the geographic placement of Stanley 
Medical College, the dietary habits (intake of spices and chillies) and 
customs carried out by local community. 
  High rates of positive findings in upper gastrointestinal 
endoscopy suggest that surgery is sometimes performed inappropriately 
in whose symptoms were not related to biliary stones. The coexistence of 
upper GI pathology should be taken into consideration during deciding 
the treatment plan to individual patients. 
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SUMMARY 
The present study is to assess the yield of upper gastrointestinal 
endoscopy in symptomatic gall stone patients in south Indian population 
and to study the frequency of various organic causes and reason of 
dyspepsia in these patients. 
The sample in this study consisted of 112 dyspepsia cases with 
females and males either attending general surgery out patient department 
at Stanley Medical College and Hospital or those referred from other 
Departments in Stanley Medical college hospital or from other hospitals. 
The findings are noted in the proforma who underwent upper 
gastrointestinal endoscopy at the general surgery department endoscopy 
room along with details of their socio-demographic variables physical 
examination and history. 
All the patients underwent cholecystectomy after they were 
diagnosed as having gallstone disease and were not followed up. The data 
analysed and the prevalence of positive findings, their age and sex 
distribution tabulated. 
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The prevalence of significant lesions was found to be higher than 
normal study in our institution. The prevalence of positive findings were 
higher in females than males. The prevalence also decreased with age and 
prevalence were highest in above 40 years of age group. 
The most common findings on endoscopy in this study is gastritis 
about half of the patient had this findings and then comes duodenitis. The 
other common findings are reflux esophagitis and hiatus hernia. The 
other findings are duodenal ulcer and gastric ulcer which is less 
compared to other findings. 
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CONCLUSION 
The prevalence of significant findings in upper gastrointestinal 
scopy of ultrasound proven symptomatic gall stone disease with chronic 
dyspepsia as symptoms is relatively higher than the prevalence of normal 
study. 
The significant findings in symptomatic patients prevalence is 
higher in females than males in all age groups. 
The prevalence of significant lesions was highest in the age group 
of >40 years. Increase in the age will be increase in the associated 
significant findings. 
The prevalence of gastritis as a single diagnoses is more prevalent 
in this part of the world and in our institution. 
Gall stone disease clinical symptoms is complex and may resemble 
other upper gastrointestinal disease. So using a upper GI scope should be 
made routine for all gall stone disease patients prior to elective surgical 
cholecystectomy. As it helps to identify other potential medically 
treatable diseases and hence cholecystectomy rates can be reduced. The 
postoperative persistence of symptoms will reduce due to single 
investigation. Thus upper gastrointestinal endoscopy has a very important 
and vital role in initial evaluation and investigation of patients with 
symptomatic gall stone disease. 
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LIMITATIONS AND SUGGESTION 
This study is an attempt to emphasize that pre op endoscopy of all 
symptomatic gall stones disease patients presenting with chronic 
dyspeptic symptoms is an useful investigation as it shows that the 
majority of the patients show significant lesions on endoscopy. 
Whether these are just incidental findings or whether these are the 
cause of the patients symptoms in the first place is subject to debate. Thus 
a useful suggestions is to treat the patient medically whose positive 
findings in endoscopy for a specific period and see for resolution of 
symptoms, if the patients have persistent symptoms the patients should 
undergo cholecystectomy. 
In the present study the size of the sample is small hence the study 
results cannot be extrapolated to the all the population. 
The study was conducted in teritiary hospital so many patients may 
had been referred here after treatment by general physician by 
conservative method and hence this may account for more positive 
findings. 
Inter observer variations may interfere with this descriptive study 
of endoscopic findings. 
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PROFORMA 
 
NAME   :                                                                                              
SL.NO   : 
AGE/SEX   : 
ADDRESS WITH  
CONTACT NUMBER : 
 
IP NO   : 
DATE OF ADMISSION : 
DATE OF SURGERY : 
DATE OF DISCHARGE : 
SYMPTOMS: 
1. PAIN/DISCOMFORT IN UPPER ABDOMEN Y/N 
2. NAUSEA        Y/N 
3. VOMITING       Y/N 
4. EARLY SATIETY     Y/N 
5. EPIGASTRIC FULLNESS    Y/N 
6. REGURGITATION     Y/N 
 
ULTRASOUND FINDINGS : 
 
UPPER GI ENDOSCOPY FINDINGS: 
 
BIOPSY TAKEN/NOT: 
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GOVT.STANLEY MEDICAL COLLEGE, CHENNAI- 600 001 
 
INFORMED CONSENT 
 
DISSERTATION TOPIC:   
“A Descriptive study of upper gastrointestinal endoscopy findings in 
symptomatic gallstone disease patients in our institution” 
PLACE OF STUDY:  
GOVT. STANLEY MEDICAL COLLEGE, CHENNAI  
NAME AND ADDRESS OF PATIENT: 
 
I, _____________________ have been informed about the details of the 
study in my own language. 
 
I have completely understood the details of the study. 
 
I am aware of the possible risks and benefits, while taking part in the 
study. 
 
I understand that I can withdraw from the study at any point of time and 
even then, I will continue to receive the medical treatment as usual. 
 
I understand that I will not get any payment for taking part in this study. 
 
I will not object if the results of this study are getting published in any 
medical journal, provided my personal identity is not revealed. 
 
I know what I am supposed to do by taking part in this study and I 
assure that I would extend my full co-operation for this study. 
 
 
 
Name and Address of the Volunteer:             Name and signature of investigator  
 
Date: 
 
Signature/Thumb impression of the Volunteer 
 
Date: 
 
 
 
 
 
 
 
Witnesses: (Signature, Name & Address) 
 
 
85 
அரசு ஸ்டான்லி மருத்துவ கல்லூாி,  
சென்னை – 600001 
 “A Descriptive study of upper gastrointestinal 
endoscopy findings in symptomatic gallstone disease 
patients in our institution” 
நான் இந்த ஆராய்ச்ெியில் விவரங்கனைமுற்றிலும்புாிந்துசகாண்டடன். 
ஆய்வில் பங்கு எடுத்து டபாது, ொத்தியமாை அபாயங்கள் மற்றும் 
பயன்கனை பற்றி நான் அறிந்துள்டைன். 
நான் எந்தசவாரு டவனையிலும் ஆய்வில் இருந்து திரும்பமுடியும், அதன் 
பின்ைர், நான் வழக்கம் டபால் மருத்துவ ெிகிச்னெ சபறமுடியும் என்று புாிந்து 
சகாள்கிடறன். 
நான் ஆய்வில் பங்கு எடுத்து பணம் எனதயும் சபறமுடியாது என்று 
அறிந்துள்டைன். 
இந்த ஆய்வின் முடிவுகள் எந்த சமடிக்கல் ஜர்ைலில் சவைியிடப்பட 
இருந்தால் நான் எதிர்க்கவில்னை,  
என் தைிப்பட்ட அனடயாைத்னத சவைிப்படுத்தப்பட்டு இருக்ககூடாது. 
நான் இந்த ஆய்வில் பங்சகடுப்பதன் மூைம் நான் என்ை 
செய்யடபாகிடறன் என்று சதாியும் 
நான் இந்த ஆய்வில் என் முழு ஒத்துனழப்னபயும் சகாடுப்டபன் என்று 
உறுதியைிக்கிடறன். 
தன்ைார்வைர்      ொட்ெி  
சபயர்மற்றும்முகவாி     சபயர்மற்றும்முகவாி 
னகசயாப்பம் / விரல்டரனக:     னகசயாப்பம் / விரல்டரனக: 
 
 
ஆராய்ச்ெியாைராக னகசயாப்பம் மற்றும் டததி 
 
S.
NO
NAME AGE SEX I.P NO. ENDOSCOPY FINDINGS
GAS
TRITIS
GAS
TRIC 
ULCER
DUO
DENITIS
DUO
DENAL 
ULCER
HIATUS 
HERNIA
REFLUX 
ESOPHA
GITIS
NORMAL 
STUDY
1 MINNALA 45 F 1567379 GASTRITIS/DUODENITIS YES NO YES NO NO NO NO
2 ABDUL HUSSAIN 35 M 1568819 GASTRITIS YES NO NO NO NO NO NO
3 MANJU 25 F 1571384 NORMAL STUDY NO NO NO NO NO NO YES
4 MEERA 37 F 1570527 REFLUX ESOPHAGITIS NO NO NO NO NO YES NO
5 BABY 30 F 1624855 GASTRITIS/DUODENITIS YES NO YES NO NO NO NO
6 KABILA 40 F 1631657 DUODENITIS NO NO YES NO NO NO NO
7 KAMALA 70 F 1639510 GASTRITIS YES NO NO NO NO NO NO
8 NAGAMMA 65 F 1642004 GASTRITIS/DUODENITIS YES NO YES NO NO NO NO
9 BHAVANI MARIAMMAL 28 F 1642598 GASTRTIS YES NO NO NO NO NO NO
10 VAUMATHY 31 F 1642682 NORMAL STUDY NO NO NO NO NO NO YES
11 SHAMEEM 40 F 1618843 REFLUX ESOPHAGITIS/GASTRITISYES NO NO NO NO YES NO
12 REVATHY 45 F 1619982 NORMAL STUDY NO NO NO NO NO NO YES
13 SUMATHI 37 F 1627019 REFLUX ESOPHAGITIS NO NO NO NO NO YES NO
14 LAXMI 37 F 1652319 GASTRITIS YES NO NO NO NO NO NO
15 JOTHI 30 F 1652531 NORMAL STUDY NO NO NO NO NO NO YES
16 KRISHNAVENI 55 F 1652499 DUODENITIS NO NO YES NO NO NO NO
17 BALRAJ 40 M 1570773 REFLUX ESOPHAGITIS/GASTRITISYES NO NO NO NO YES NO
18 SHANMUGAPRIYA 33 F 1607608 DUODENITIS NO NO YES NO NO NO NO
19 LILLYPUSHPAM 27 F 1617222 GASTRITIS/DUODENITIS YES NO YES NO NO NO NO
20 DEVI 33 F 1595873 NORMAL STUDY NO NO NO NO NO NO YES
21 NIRMALA 25 F 1590720 REFLUX ESOPHAGITIS NO NO NO NO NO YES NO
22 AGASTIN 74 M 1592482 GASTRITIS YES NO NO NO NO NO NO
23 RAGUNATH 50 M 1594758 GASTRITIS YES NO NO NO NO NO NO
24 VANITHA 38 F 1595775 GASTRITIS YES NO NO NO NO NO NO
25 RAHAMATH NISHA 64 F 1604656 DUODENAL ULCER NO NO NO YES NO NO NO
26 JAMILA 55 F 1608478 NORMAL STUDY NO NO NO NO NO NO YES
27 BHAVANI 60 F 1627277 REFLUX ESOPHAGITIS/DUODENITISNO NO YES NO NO YES NO
28 SHANTHAKUMARI 60 F 1603585 GASTRIC ULCER/DUODENITIS YES YES YES NO NO NO NO
29 DEEPA 34 F 1612934 HIATUS HERNIA NO NO NO NO YES NO NO
30 LAKSHMI 37 F 1625325 GASTRITIS/DUODENITIS YES NO YES NO NO NO NO
31 BHUVANESWARI 34 F 1625325 GASTRITIS/DUODENAL ULCER YES NO NO YES NO NO NO
32 VENKATESAN 68 M 1627031 GASTRTIS/DUODENITIS YES NO YES NO NO NO NO
33 MAMMUTHA BEEVI 56 F 1626613 DUODENITIS NO NO YES NO NO NO NO
34 SHEIK MOHAMMED 36 M 1641251 REFLUX ESOPHAGITIS NO NO NO NO NO YES NO
35 AJAYKUMAR 31 M 1648735 NORMAL STUDY NO NO NO NO NO NO YES
36 GEETHA 22 F 1572024 GASTRITIS/DUODENITIS YES NO YES NO NO NO NO
37 MANJULA 34 F 1619256 GASTRITIS/DUODENITIS YES NO YES NO NO NO NO
38 KAVITHA 32 F 1639600 NORMAL STUDY NO NO NO NO NO NO YES
39 KOMALA 45 F 1639629 REFLUX ESOPHAGITIS NO NO NO NO NO YES NO
40 KARTHIK 31 M 1650961 NORMAL STUDY NO NO NO NO NO NO YES
41 NAGAMMAL 50 F 1651186 GASTRITIS YES NO NO NO NO NO NO
42 ALAMELU 58 F 1593640 DUODENITIS NO NO YES NO NO NO NO
43 PARVATHY 39 F 1600640 NORMAL STUDY NO NO NO NO NO NO YES
44 MANJULA 40 F 1605661 HIATUS HERNIA NO NO NO NO YES NO NO
45 ALAMELU 39 F 1600656 GASTRITIS/DUODENITIS YES NO YES NO NO NO NO
46 VIMALA 54 F 1607428 DUODENITIS NO NO YES NO NO NO NO
47 SANJU 27 M 1608781 HIATUS HERNIA NO NO NO NO YES NO NO
48 RAJALAKSHMI 45 F 1610275 HIATUS HERNIA/DUODENITIS NO NO YES NO YES NO NO
49 LAKSHMI 40 F 1611879 DUODENITIS NO NO YES NO NO NO NO
50 DESAPPAN 44 M 1610914 NORMAL STUDY NO NO NO NO NO NO YES
51 BALAKRISHNAN 54 M 1610612 GASTRTIS YES NO NO NO NO NO NO
52 VIJAYA 34 F 1615049 REFLUX ESOPHAGITIS/GASTRTISYES NO NO NO NO YES NO
53 KAIRUNISHA 28 F 1621464 GASTRITIS YES NO NO NO NO NO NO
54 ANANDHAN 68 M 1616619 REFLUX ESOPHAGITIS/GASTRTISYES NO NO NO NO YES NO
55 SUGUNA 45 F 1618160 REFLUX ESOPHAGITIS/GASTRITISYES NO NO NO NO YES NO
56 MAHALAKSHMI 70 F 1621050 GASTRTIS YES NO NO NO NO NO NO
57 JAINABEEVI 63 F 1619651 GASTRTIS/DUODENITIS YES NO YES NO NO NO NO
58 ABDUL RAHEEM 48 F 1629066 NORMAL STUDY NO NO NO NO NO NO YES
59 RAJAN 73 M 1636906 GASTRTIS/DUODENITIS YES NO YES NO NO NO NO
60 KALAISELVI 26 M 1640703 NORMAL STUDY NO NO NO NO NO NO YES
61 THIRUPLAMMAL 30 F 1636873 GASTRITIS YES NO NO NO NO NO NO
62 MUNUSAMY 52 M 1642064 DUODENITIS/GASTRITIS YES NO YES NO NO NO NO
63 KAMINI 55 F 1643526 GASTRIC ULCER/DUODENITIS YES YES YES NO NO NO NO
64 JANAKI 67 F 1645282 HIATUS HERNIA NO NO NO NO YES NO NO
65 LATHA 40 F 1643571 NORMAL STUDY NO NO NO NO NO NO YES
66 ALIMABEEVI 57 F 1647021 REFLUX ESOPHAGITIS/GASTRITISYES NO NO NO NO YES NO
67 BHUVANESWARI 36 F 1524260 NORMAL STUDY NO NO NO NO NO NO YES
68 MARIYAMMAL 40 F 1533243 HIATUS HERNIA NO NO NO NO YES NO NO
69 MALAR 32 F 1528041 NORMAL STUDY NO NO NO NO NO NO YES
70 JAINABEE 48 F 1536759 NORMAL STUDY NO NO NO NO NO NO YES
71 FATHIMA BEEVI 45 F 1535574 GASTRITIS YES NO NO NO NO NO NO
72 DILSHATH 27 F 1537907 NORMAL STUDY NO NO NO NO NO NO YES
73 HEMALATHA 23 F 1540823 NORMAL STUDY NO NO NO NO NO NO YES
74 CHANDRAN 51 M 1542295 REFLUX ESOPHAGITIS NO NO NO NO NO YES NO
75 TAMILSELVI 46 F 1539397 NORMAL STUDY NO NO NO NO NO NO YES
76 ELUMALAI 53 M 1542323 GASTRITIS YES NO NO NO NO NO NO
77 BHARATHIABE 66 F 1545321 GASTRITIS YES NO NO NO NO NO NO
78 SAMSATH BEGUM 34 F 1545321 NORMAL STUDY NO NO NO NO NO NO YES
79 MUTHUPANDI 21 M 1546877 DUODENITIS NO NO YES NO NO NO NO
80 RAJESHWARI 30 F 1548295 HIATUS HERNIA NO NO NO NO YES NO NO
81 MUTHULAKSHMI 28 F 1548057 GASTRITIS YES NO NO NO NO NO NO
82 LAKSHMI 19 F 1552737 NORMAL STUDY NO NO NO NO NO NO YES
83 SUSEELA 50 F 1554248 GASTRITIS YES NO NO NO NO NO NO
84 SIRAJUNISHA 67 F 1552746 GASTRITIS YES NO NO NO NO NO NO
85 SHANKAR 35 M 1554190 HIATUS HERNIA/GASTRITIS YES NO NO NO YES NO NO
86 GURUSAMY 50 M 1556181 GASTRITIS YES NO NO NO NO NO NO
87 PATTU 38 F 1556906 GASTRITIS/DUODENITIS YES NO YES NO NO NO NO
88 VIJAY 27 M 1556886 GASTRITIS YES NO NO NO NO NO NO
89 RAJAMMAL 45 F 1557021 NORMAL STUDY NO NO NO NO NO NO YES
90 KALI 54 M 1555395 DUODENITIS NO NO YES NO NO NO NO
91 SIVAMANGALAM 46 M 1562434 GASTRITIS YES NO NO NO NO NO NO
92 JHANSI 26 F 1566041 NORMAL STUDY NO NO NO NO NO NO YES
93 ALAMELU 33 F 1565499 GASTRITIS YES NO NO NO NO NO NO
94 MOHAMMED YUSUF 48 M 1566818 GASTRITIS YES NO NO NO NO NO NO
95 VASUDEVAN 57 M 1570341 DUODENITIS/GASTRITIS YES NO YES NO NO NO NO
96 NIRMALA 44 F 1569501 GASTRITIS YES NO NO NO NO NO NO
97 SENGALVARAYAN 60 M 1557634 GASTRITIS YES NO NO NO NO NO NO
98 NAVANEETHAM 40 F 1551574 NORMAL STUDY NO NO NO NO NO NO YES
99 SEENATH 38 F 1552216 NORMAL STUDY NO NO NO NO NO NO YES
100 KULANJI 55 F 1551494 GASTRITIS YES NO NO NO NO NO NO
101 MUTHU 53 M 1553050 HIATUS HERNIA/GASTRITIS YES NO NO NO YES NO NO
102 RAMYA 15 F 1557314 NORMAL STUDY NO NO NO NO NO NO YES
103 MURUGAN 75 M 1557433 GASTRITIS YES NO NO NO NO NO NO
104 ANITHA 32 F 1593523 HIATUS HERNIA NO NO NO NO YES NO NO
105 VIJAYA 38 F 1592906 NORMAL STUDY NO NO NO NO NO NO YES
106 PREMA 50 F 1569076 GASTRITIS YES NO NO NO NO NO NO
107 JEYANTHI 25 F 1571036 GASTRTIS YES NO NO NO NO NO NO
108 ANANTHI 28 F 1569144 DUODENITIS NO NO YES NO NO NO NO
109 CHELLADURAI 36 M 1567596 NORMAL STUDY NO NO NO NO NO NO YES
110 KURSHID 40 F 1564803 HIATUS HERNIA NO NO NO NO YES NO NO
111 VANAJA 40 F 1562944 DUODENITIS NO NO YES NO NO NO NO
112 KUSHALDOSS 56 M 1556347 NORMAL STUDY NO NO NO NO NO NO YES
